{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:10:01Z","timestamp":1790644201382,"version":"4.1.0"},"reference-count":45,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mol Med"],"DOI":"10.3892\/ijmm.2018.3818","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T10:03:07Z","timestamp":1533808987000},"source":"Crossref","is-referenced-by-count":9,"title":["Epigallocatechin-3-gallate affects the proliferation, apoptosis, migration and invasion of tongue squamous cell carcinoma through the hippo-TAZ signaling pathway"],"prefix":"10.3892","author":[{"given":"Aonan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Implantology, School of Stomatology, Shandong\ufffdUniversity, Jinan, Shandong\ufffd250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Implantology, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Implantology, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Implantology, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xucheng","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Implantology, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Implantology, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Implantology, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"key20200713175822_b1-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"key20200713175822_b2-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20200713175822_b3-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12032-018-1096-5","article-title":"Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: A systematic review","volume":"35","author":"Guidi","year":"2018","journal-title":"Med Oncol"},{"key":"key20200713175822_b4-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1056\/NEJMra0707975","article-title":"Recent advances in head and neck cancer","volume":"359","author":"Haddad","year":"2008","journal-title":"N Engl J Med"},{"key":"key20200713175822_b5-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"key20200713175822_b6-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1200\/JCO.2005.05.3348","article-title":"Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck","volume":"24","author":"Colevas","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20200713175822_b7-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10787-015-0236-1","article-title":"Green tea polyphenols and their potential role in health and disease","volume":"23","author":"Afzal","year":"2015","journal-title":"Inflammopharmacology"},{"key":"key20200713175822_b8-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1631\/jzus.B1500001","article-title":"Tea and human health: Biomedical functions of tea active components and current issues","volume":"16","author":"Chen","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"key":"key20200713175822_b9-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/hed.20830","article-title":"Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer","volume":"30","author":"Hamakawa","year":"2008","journal-title":"Head Neck"},{"key":"key20200713175822_b10-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3892\/or.2012.1991","article-title":"Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2","volume":"28","author":"Chang","year":"2012","journal-title":"Oncol Rep"},{"key":"key20200713175822_b11-ijmm-42-05-2615","first-page":"461","article-title":"Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells","volume":"8","author":"Irimie","year":"2015","journal-title":"Onco Targets Ther"},{"key":"key20200713175822_b12-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"30233","DOI":"10.1038\/srep30233","article-title":"Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells","volume":"6","author":"Kanlaya","year":"2016","journal-title":"Sci Rep"},{"key":"key20200713175822_b13-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.canlet.2015.02.034","article-title":"Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells","volume":"360","author":"Lee","year":"2015","journal-title":"Cancer Lett"},{"key":"key20200713175822_b14-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/biof.1185","article-title":"Green tea polyphenol EGCG suppresses Wnt\/\u03b2-catenin signaling by promoting GSK-3\u03b2- and PP2A-independent \u03b2-catenin phosphorylation\/degradation","volume":"40","author":"Oh","year":"2014","journal-title":"Biofactors"},{"key":"key20200713175822_b15-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.phymed.2016.07.005","article-title":"Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of \u03b2-catenin","volume":"23","author":"Shin","year":"2016","journal-title":"Phytomedicine"},{"key":"key20200713175822_b16-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"540148","DOI":"10.1155\/2011\/540148","article-title":"Chemoprevention of head and neck cancer by green tea extract: EGCG-The role of EGFR signaling and 'lipid raft'","volume":"2011","author":"Masuda","year":"2011","journal-title":"J Oncol"},{"key":"key20200713175822_b17-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The Hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20200713175822_b18-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","article-title":"The hippo signaling pathway in development and cancer","volume":"19","author":"Pan","year":"2010","journal-title":"Dev Cell"},{"key":"key20200713175822_b19-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1158\/1541-7786.MCR-14-0580","article-title":"A YAP\/TAZ-regulated molecular signature is associated with oral squamous cell carcinoma","volume":"13","author":"Hiemer","year":"2015","journal-title":"Mol Cancer Res"},{"key":"key20200713175822_b20-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.molonc.2015.01.007","article-title":"The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer","volume":"9","author":"Li","year":"2015","journal-title":"Mol Oncol"},{"key":"key20200713175822_b21-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PcR and the 2\u2212\u0394\u0394C T method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713175822_b22-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00432-014-1803-3","article-title":"Current clinical regulation of PI3K\/PTEN\/Akt\/mTOR signalling in treatment of human cancer","volume":"141","author":"Lim","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20200713175822_b23-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"key20200713175822_b24-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00204-014-1448-7","article-title":"The mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update","volume":"89","author":"Siddiqui","year":"2015","journal-title":"Arch Toxicol"},{"key":"key20200713175822_b25-ijmm-42-05-2615","first-page":"218","volume-title":"PARP inhibitors for cancer therapy In: Poly(ADP-Ribosyl)ation Molecular Biology Intelligence Unit","author":"Curtin","year":"2006"},{"key":"key20200713175822_b26-ijmm-42-05-2615","first-page":"6","article-title":"EMT and tumor metastasis","volume":"4","author":"Heerboth","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"key20200713175822_b27-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00432-014-1899-5","article-title":"Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds","volume":"141","author":"Fujiki","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20200713175822_b28-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key20200713175822_b29-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0976-9668.127272","article-title":"Chemoprevention of oral cancer: Green tea experience","volume":"5","author":"Ramshankar","year":"2014","journal-title":"J Nat Sci Biol Med"},{"key":"key20200713175822_b30-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/mnfr.201400485","article-title":"The differential pro-oxidative effects of the green tea polyphenol, (\u2212)-epigallocatechin-3-gallate, in normal and oral cancer cells are related to differences in sirtuin 3 signaling","volume":"59","author":"Tao","year":"2015","journal-title":"Mol Nutr Food Res"},{"key":"key20200713175822_b31-ijmm-42-05-2615","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1007\/978-3-662-46875-3_4249","volume-title":"Oral cancer In: Encyclopedia of Cancer","author":"Martinez","year":"2017"},{"key":"key20200713175822_b32-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.oraloncology.2015.10.012","article-title":"Improved prognosis for patients with oral cavity squamous cell carcinoma: Analysis of the National Cancer Database 1998\u20132006","volume":"52","author":"Schwam","year":"2016","journal-title":"Oral Oncol"},{"key":"key20200713175822_b33-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.3892\/mmr.2015.4118","article-title":"A genome-wide study of DNA methylation modified by epigallocatechin-3-gallate in the CAL-27 cell line","volume":"12","author":"Chen","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20200713175822_b34-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1110955","article-title":"TAZ, a transcriptional modulator of mesenchymal stem cell differentiation","volume":"309","author":"Hong","year":"2005","journal-title":"Science"},{"key":"key20200713175822_b35-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jop.12062","article-title":"Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: Correlation with clini-copathological features and patients' prognosis","volume":"42","author":"Wei","year":"2013","journal-title":"J Oral Pathol Med"},{"key":"key20200713175822_b36-ijmm-42-05-2615","first-page":"247","article-title":"Regulation and function of the TAZ transcription co-activator","volume":"2","author":"Liu","year":"2011","journal-title":"Int J Biochem Mol Biol"},{"key":"key20200713175822_b37-ijmm-42-05-2615","first-page":"405","article-title":"Effects of EGCG on the proliferation and apoptosis of human oral squamous cell carcinoma Tca8113 cell line","volume":"28","author":"Ren","year":"2012","journal-title":"J Oral Sci"},{"key":"key20200713175822_b38-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jdsr.2010.01.004","article-title":"Apoptosis-inducing activity and tumor-specificity of antitumor agents against oral squamous cell carcinoma","volume":"46","author":"Sakagami","year":"2010","journal-title":"Jpn Dent Sci Rev"},{"key":"key20200713175822_b39-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ejphar.2013.05.008","article-title":"Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma","volume":"715","author":"Hwang","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"key20200713175822_b40-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","article-title":"Mechanisms of Hippo pathway regulation","volume":"30","author":"Meng","year":"2016","journal-title":"Genes Dev"},{"key":"key20200713175822_b41-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"8357","DOI":"10.1038\/ncomms9357","article-title":"MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway","volume":"6","author":"Meng","year":"2015","journal-title":"Nat Commun"},{"key":"key20200713175822_b42-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tplants.2004.01.005","article-title":"Reassessing the MAP3K and MAP4K relationships","volume":"9","author":"Champion","year":"2004","journal-title":"Trends Plant Sci"},{"key":"key20200713175822_b43-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"ra81","DOI":"10.1126\/scisignal.2004324","article-title":"Ajuba family proteins link JNK to Hippo signaling","volume":"6","author":"Sun","year":"2013","journal-title":"Sci Signal"},{"key":"key20200713175822_b44-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"e2688","DOI":"10.1038\/cddis.2017.18","article-title":"Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K\/Akt\/mTOR signaling pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis"},{"key":"key20200713175822_b45-ijmm-42-05-2615","doi-asserted-by":"publisher","first-page":"946","DOI":"10.18632\/oncotarget.5834","article-title":"The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer","volume":"7","author":"Stine","year":"2016","journal-title":"Oncotarget"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T18:54:05Z","timestamp":1594666445000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2018.3818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3892\/ijmm.2018.3818","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]}}}